Welcome to Paid Research Studies


Browse Locations ... United States» ... Massachusetts» ... Cambridge






  • Condition:   Non-Infectious Anterior Uveitis
    Interventions:   Drug: 8% Dexamethasone Sodium Phosphate - Visulex;   Drug: 15% Dexamethasone Sodium Phosphate - Visulex;   Drug: Prednisolone Acetate (1%) Eye Drops
    Sponsors:   Aciont Inc;   National Eye Institute (NEI)
    Recruiting - verified January 2015

  • Conditions:   Uveitis;   Macular Edema;   Uveitis, Posterior;   Uveitis, Anterior;   Panuveitis;   Uveitis, Intermediate
    Interventions:   Drug: 4 mg CLS-TA;   Drug: 0.8 mg CLS-TA
    Sponsor:   Clearside Biomedical, Inc.
    Recruiting - verified January 2015

  • Condition:   Uveitis
    Interventions:   Drug: Sarilumab SAR153191/REGN88;   Drug: Prednisone;   Drug: Methotrexate;   Drug: Folic/folinic acid;   Other: Sarilumab (SAR153191/REGN88) placebo
    Sponsor:   Sanofi
    Recruiting - verified January 2015

  • Condition:   Uvea; Posterior, Disorder
    Interventions:   Drug: DE-109;   Drug: DE-109;   Drug: DE-109
    Sponsor:   Santen Inc.
    Recruiting - verified January 2015

  • Conditions:   Estrogen Receptor Negative;   Estrogen Receptor Positive;   HER2/Neu Positive;   Progesterone Receptor Negative;   Progesterone Receptor Positive;   Recurrent Breast Carcinoma;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage IIA Breast Cancer;   Stage IIB Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIC Breast Cancer
    Interventions:   Drug: Doxorubicin Hydrochloride;   Drug: Docetaxel;   Drug: Cyclophosphamide;   Biological: Trastuzumab;   Drug: Paclitaxel;   Other: Quality-of-Life Assessment;   Other: Laboratory Biomarker Analysis
    Sponsor:   National Cancer Institute (NCI)
    Recruiting - verified January 2015